DRUG (Brand DOSAGE

MECHANISM OF
name and CLASSIFICATION
ACTION
Generic name)
OB WARD
Ferrous Sulfate Pharmacologic: Elevates the serum iron
(Femiron, Hemocyte, Iron preparation concentration, and is then
Ircon) converted to Hgb or trapped in the deficiency anemias
Therapeutic: reticuloendothelial cells for
Iron Preparation storage and eventual conversion to
a usable form of iron
Pregnancy Category Risk: A
Cefuroxime (Ceftin) Chemical: a second-generation
 Cephalosporin cephalosporin that bind to
bacterial cell membranes and
 Antibiotic inhibits cell wall synthesis
Pregnancy category risk: B Therapeutic: Bactericidal; inhibits sinusitis, tonsilitis, and
synthesis of bacterial cell wall,
causing cell death
Magnesium Sulfate Anticonvulsant Cofactor of many enzyme systems
involved in neurochemical
Pregnancy category risk: D transmission and muscular
excitability; prevents or controls
seizures by blocking
neuromuscular transmission;
attracts and retains water in the
intestinal lumen and distends
bowel to promote mass movement
and relieve constipation
Mefenamic acid CNS agent; analgesic; nsaid; Anthranilic acid derivative. Like Hypersensitivity to
(Ponstel) antipyretic ibuprofen inhibits prostaglandin drug; GI inflammation, adult: PO leading Dose 500 nervousness, confusion, headache.
synthesis and affects platelet
Pregnancy category risk: C function. No evidence that it is
superior to aspirin.
INDICATION (Recommended and ADVERSE REACTIONS NURSING RESPONSIBILITIES
Actual)
Prevention and 19-50 years CNS: CNS toxicity, acidosis, coma and Before:
treatment of iron- Males: 8 mg/day death with overdose >Check the doctor’s order
Females: 18 mg/day >Assess for allergy to any ingredients
Pregnant females: 27 GI: GI upset, anorexia, nausea, vomiting, During:
mg/day constipation, diarrhea, dark stools, >Administer right drug in the right dose and route at
Lactating females: 9 temporary staining of teeth the right time
mg/day >do not crush, chew, or cut tablets and capsules
>give drug with meals
Child: 3-6 mg/kg daily in 3 After:
divided doses. >arrange for periodic monitoring of Hct and Hgb
levels
>document and record
For treatment of many PO: 250mg BID  Severe diarrhea Asses any history of allergy with this drug.
different types of many 7-10 days  Bleeding
different types of  Lethargy Culture infection, and arrange for sensitivity test
bacterial infections IV: 170mg BID  Anorexia before and during therapy if expected response is not
such as bronchitis,  Decreased platelets Hct seen.
bacterial meningitis. Give oral drug with food to decrease GI upset and
enhance absorption
For postpartum
mothers, cefuroxime is Have vit. K available in case hypoprothrombinemia
given to prevent them occurs
from post-operational
infections especially c/s Instruct the patient to report any unusuality.
mothers.
 IV or IM: 2.5g through IV CNS: weakness, dizziness, fainting, Monitor patients closely during and following
preeclampsia 5g through IM at each sweating (PO) infusions. Observe orthostatic precautions
or eclampsia buttock q6
 To correct or CV: Palpations Reserve IV use in eclampsia for immediate life-
prevent threatening situations
hypomagnese GI: Excessive bowel activity, Perianal
mia in irritations. Monitor serum magnesium levels during parenteral
patients or therapy
parenteral Metabolic: Hypermagnesemia and
nutrition toxicity in patients with renal failure
Mild to moderate pain CNS: Drowsiness, insomnia, dizziness, Assess patients who develop severe diarrhea and
vomiting for dehydration and electrolyte imbalance.
or ulceration. mg
GI: Severe, diarrhea, ulceration, and Lab test: with long- term therapy obtain periodic
Safety in children <14 PO maintenance Dose 250 bleeding; nausea, vomiting, abdominal complete blood counts, Hct and Hgb. And kidney
y, during pregnancy mg q6h prn cramps, flatus, constipation, hepatic function test.
(category C), or toxicity.
lactation is not Discontinue drug promptly if diarrhea, dark stool,
established. Hematologic: Prolonged prothrombin hematemesis, ecchymoses, epistaxis, or rash occur,
time, severe autoimmune hemolytic and do not use again. Notify physician.
anemia (long term use), leukopenia,
 eosinophilia.
Phytonadione Vitamins Promotes hepatic formation of Prevention, treatment Dosage: 0.5 ml For infants (particularly premature Monitor PT, international normalized ratio (INR)
(Vitamin K) coagulation factors II, VII, IX, X. of hemorrhagic states babies), excessive doses of vitamin K routinely in those taking anticoagulants.
Essential for normal clotting of in neonates. Antidote Route: IM analogs during the first few days of life
blood. Readily absorbed from GI for hemorrhage induced may cause hyperbilirubinemia; this in Assess gums for gingival bleeding, erythema.
tract (duodenum) after IM, by oral anticoagulants, turn may result in severe hemolytic
subcutaneous administration. hypoprothrombinemia anemia, hemoglobinuria, kernicterus, Assess urine hematuria
Metabolized in liver. Excreted in states due to vitamin K leading to brain damage or even death.
urine; eliminated by biliary deficiency. Assess skin for ecchymoses, petechiae
system. Onset of action (increased Hypoprothrombinemia Severe reaction occurs rarely, at the
coagulation factors) caused by injection sites. Assess Hct, platelet count, urine/stool culture for
malabsorption or occult blood.
inability to synthesize
vitamin k.
Erythromycin Pharmacologic: More active against gram-positive To prevent neonatal 0.5 % 1 cm Eyes: Blurred vision Cleanse the infant’s eyes as needed before
ointment (E-Mycin) Macrolide organisms than against gram- conjunctivitis and application.
antibiotic negative organism due to its ophthalmia Body as a whole: Fever, eosinophilia,
superior penetration into gram- neonatorum. urticaria, skin eruptions, fixed drug Hold the tube in a horizontal rather than a vertical
Therapeutic: positive organism. eruption, anaphylaxis. Superinfections by position.
Anti-infective nonsusceptible bacteria, yeasts, or fungi.
Do not touch the tip of the tube to any part of the eye
Skin: (topical use) Erythema,
desquamation, burning, tenderness, Administer from the inner canthus to the outer
dryness, or oiliness, pruritus. canthus

Apply 0.5 1 cm ribbon in lover conjunctival sacs

shortly after birth

Observe for irritation

Oxytocin (Pitocin, Uterine active agents By direct action on myofibrils > Initiation or Dosage: 10 units/ml in 1ml CV: Hypertension, increased heart rate, Continuously monitor contractions, fetal and maternal
Syntocinon) produces phasic contractions improvement of uterine ampule systemic venous return, cardiac output. heart rate, and maternal blood pressure and ECG
characteristic of normal delivery. contractions to achieve
Promotes milk ejection (letdown) early vaginal delivery Route: IV/IM GI: Nausea, vomiting Discontinue infusion if uterine hyperactivity occurs
reflex in nursing mother, thereby for maternal or fetal
increasing flow (not volume) of reasons (IV) Respiratory: Anoxia, asphyxia Monitor patient extremely closely during first and
milk; also facilitates flow of milk second stages of labor because of risk of cervical
during period of breast > As adjunctive therapy Others: laceration, uterine rupture and maternal and fetal
engorgement. Uterine sensitivity in the management of Low APGAR score at 5 minutes death
to oxytocin increases during inevitable or
gestation period and peaks sharply incomplete abortion Assess fluid intake and output. Watch for signs and
before parturition. Not used for (IV) symptoms of water intoxication.
elective induction of labor.
>Stimulation of uterine
contractions during
third stage of labor (IV)

>Control of postpartum
bleeding or hemorrhage
(IV, IM)